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Abstract
Background: Laboratory performance can be measured
using a set of model key performance indicators (KPIs). The
design and implementation of KPIs are important issues. KPI
results from 7 years are reported and their implementation,
monitoring, objectives, interventions, result reporting and
delivery are analyzed.
Methods: The KPIs of the entire laboratory process were
obtained using Laboratory Information System (LIS) regis-
ters. These were collected automatically using a data ware-
house application, spreadsheets and external quality program
reports. Customer satisfaction was assessed using surveys.
Nine model laboratory KPIs were proposed and measured.
Results: The results of some examples of KPIs used in our
laboratory are reported. Their corrective measurements or the
implementation of objectives led to improvement in the asso-
ciated KPIs results.
Conclusions: Measurement of laboratory performance using
KPIs and a data warehouse application that continuously col-
lects registers and calculates KPIs confirmed the reliability
of indicators, indicator acceptability and usability for users,
and continuous process improvement.
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Introduction
The rising cost of health care has stimulated interest in devel-
oping methods to increase the efficiency of health-care
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organizations through adoption of technological advances
(1). However, it is paradoxical that clinical laboratories have
embraced most technological advances for improving ana-
lytical processes, but have been slow to measure laboratory
performance using key performance indicators (KPIs).
A KPI is an objective measure for evaluating critical
health care domains (patient safety, effectiveness, equity,
patient-centeredness, timeliness and efficiency) (2). Assess-
ment of the quality of laboratory services using KPIs requires
a systematic, transparent, and consistent approach to collec-
tion and analysis of data.
The goal of the present study was to show how laboratory
performance is measured using a set of defined KPIs. The
results obtained over 7 years using these indicators are
reported, and the design, implementation, monitoring, objec-
tives, interventions, result reporting and delivery in daily
practice are described.
Materials and methods
The laboratory was an ISO 9001:2008-certified laboratory affiliated
with a public university hospital serving a population of 234,403.
It provides care for inpatients and outpatients in primary care cen-
ters. Samples were collected by a courier, transported to the labo-
ratory sample reception desk for classification and distributed to the
appropriate units where testing was conducted. Once the laboratory
physician verified the test results, clinicians could automatically
consult the report via the intranet. The clinical laboratory includes
chemistry and hematology testing. In 2008, 262,100 requests and
2,668,984 tests were preformed.
The registers used to build the nine model KPIs were ‘‘Intern
Laboratory Information System (LIS) data’’ (test registration and
test validation time and date), ‘‘Daily LIS data’’ (data necessary for
daily work: demographic information, tests requested, test results,
coded test results, etc.), and ‘‘LIS quality tests’’ (data entered man-
ually that is not necessary for daily work but records information
on incidents that occur during the course of the request). The reg-
isters and KPIs were collected and calculated automatically by the
LIS using a software program based on OLAP cubes (Omnium by
Roche Diagnostics SUNSET Technologies, Girona, Spain). Trans-
port and analytical KPI registers were recorded on spreadsheets and
in External Quality Program reports, respectively. Customer satis-
faction was assessed using internal surveys. Surveys used a scale
from 0 to 10 (0, poor and 10, excellent).
The KPI design is shown in Table 1. KPIs were classified as pre-
pre-analytical, pre-analytical, analytical and post-analytical accord-
ing to the laboratory process that they measured. The indicators
were selected to monitor all stages of the entire test process.
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Table 1 Nine model key performance indicators.
Indicator Source register Design Periodicity
Pre-pre-analytical
Appropriateness test request Daily LIS data Tests requested/control tests requested Monthly
Pre-analytical
Customer satisfaction Survey Average score Annually
Demographic register Daily LIS data Incorrect demographic register requests/total requests Monthly
Unsuitable specimen Daily LIS data Unsuitable specimen/total specimens Monthly
Transport Spreadsheet Days that the courier does not meet established time Monthly
objective/total days
Analytical
Proficiency testing External quality Test with Sigma value )3/total tests Quarterly
program
Post-analytical
Turnaround time Intern LIS data Median (TAT, between test register and verification) Monthly
Verified in the phlebotomy day Intern LIS data Key tests verified the phlebotomy day/total key tests Monthly
Clinician satisfaction Survey Average score Annually
Nine key performance indicators, including the name, construction, and periodicity of delivery of indicator results.
The pre-pre-analytical KPI, or appropriateness indicator, referred
to the test request. It measured the number of tests processed per
control tests requested.
Patient satisfaction surveys with respect to phlebotomy were con-
sidered as one of the four pre-analytical indicators. The KPI dem-
ographic register revealed any omission of demographic items (age,
requesting doctor, suspected diagnosis, etc.) per total requests. The
next KPI referred to unsuitable specimens. These indicators were
monitored by defining pre-analytical sample error as a rejected spec-
imen: any sample that was not suitable for one or more tests in the
total order because the specimen did not meet acceptability criteria,
or the sample was not received (3). The pre-analytical error (coded
result that informed of a specific error and recommended collection
of a new specimen) and the sample in which the error occurred
were collected to calculate the KPI. The last pre-analytical KPI was
the transport indicator. The data used to calculate the transport KPI
was the number of days that the courier failed to meet the estab-
lished time objective.
The analytical KPIs were calculated from the external quality
program report. This report was based on Six-Sigma results (4) and
reported every 3 months to each functional unit.
The post-analytical KPIs showed the percentage of key tests
requested that were completed, verified and made available to the
requesting doctor on the day of phlebotomy, and manual test turn-
around time (TAT) in days (TAT between test registration and ver-
ification). Clinician satisfaction with laboratory service was also
considered in the post-analytical KPIs.
All the KPIs were expressed as percentages, except for TAT
(days) and customer satisfaction KPIs (average score). One KPI
result for every model KPI from January 2002 to February 2009 is
shown. Indicator results were entered into the SPSS 14.0 for Win-
dows (SPSS Inc, Chicago, IL, USA) and Microsoft Office Excel
2003 for statistical analysis.
Results
Six KPI results are shown in Figure 1, arranged from A to
F and classified according to the laboratory process. Indi-
cator results not shown in the Figure are described in the
text.
The pre-pre-analytical KPI (test appropriateness indicator)
was the ratio of requests for C-reactive protein (CRP) to
requests for glucose by the emergency department (ED).
Given the increase in ED stat CRP requests (9285, 16,997
and 20,753 in 2006, 2007 and 2008, respectively), a multi-
disciplinary working group consisting of emergency room,
laboratory, rheumatology, pediatric and infectious disease
clinicians was established to design a CRP request protocol
for implementation in clinical sessions. The decline in CRP
requests lasted 5 months only. Subsequently, the protocol was
circulated every 2 months with a short note indicating the
importance of an appropriate request for CRP, and KPI evo-
lution to every clinician, but without success (Figure 1A).
Patient requests containing the correct demographic data
(age) improved when automatic collection of demographic
registers from a government database was implemented in
April 2008 (Figure 1B).
Two corrective measures were introduced into transport
circuits (May 2005 and September 2007), which rapidly
reduced the number of specific transport KPIs (Figure 1C).
These interventions consisted of reorganizing the sample col-
lection route among the decentralized phlebotomy centers.
As an example of an unsuitable specimen KPI, we report-
ed the number of samples clotted and unavailable for meas-
urement of the erythrocyte sedimentation rate (ESR). The
removal of a specific ESR tube in July 2003 resulted in an
immediate improvement of the number of clotted and un-
available ESR sample KPIs (Figure 1D). As a pre-analytical
indicator, we used patient satisfaction with phlebotomy,
which improved over the past several years (average scores
7.5, 7.7, 7.9, 8 and 8.3 since 2004).
The analytical indicator report showed the number of tests
with Sigma value -3 and with values )3. The Sigma -3
bar indicated the number of tests that did not meet the target.
This report was sent monthly to all functional units in the
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Figure 1. Results of key performance indicators.
The results of six KPIs representative of steps in the laboratory process. (A) Appropriateness test request indicator: measurement of C-
reactive protein (CRP) per glucose request in the ED. (B) Demographic register indicator: % of requests without age per total requests. (C)
Transport indicator: the number of days that the courier does meet target delivery time per total number of days. (D) Unsuitable specimen
indicator: the number of clotted samples and samples unavailable for ESR, per thousand ESR samples collected. (E) Verified on the day
of phlebotomy indicator: the monthly delivery of TSH verified at 3 p.m., and subsequent implementation of the objectives (99% for inpatients
and 90% for primary care patients since May 2006) and recently (November 2008). Eighty-five percent for inpatients at 12 a.m. on the day
of phlebotomy indicated progressive improvement in the indicator result. (F) Turnaround time indicator: median TAT for ANA.
laboratory. For example, in January 2009 in the chemistry
functional unit, all the tests were Sigma )3 except for albu-
min, calcium, sodium and potassium.
Thyroid-stimulating hormone (TSH), verified on the day
of phlebotomy, showed progressive improvement in the indi-
cator result (Figure 1E). The TAT for antinuclear antibodies
(ANA) for samples from inpatients also improved after
objective implementation (3 days) in June 2007 (Figure 1F).
Clinician satisfaction (post-analytical indicator) improved
over the past several years from 7 to 8 since 2004.
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Discussion
The results of a series of KPIs that are representative of every
step of the laboratory process are reported. As Shahangian
states, there is a general lack of evidence to support the
importance, scientific soundness and usefulness of most of
these indicators because laboratories generally do not publish
their internal monitoring data (5). Therefore, our aim was to
elucidate aspects of the indicators for the purpose of contin-
uous quality improvement. However, each laboratory should
design its own indicators based on laboratory organization
and processes (6).
The pre-pre-analytical KPI chosen was a simple indicator
of test appropriateness. It showed the evolution of a specific
test compared with another widely used test. This allows
corrective measures to be taken when any monthly deviation
occurs, in addition to monitoring the measures. The CRP
post-intervention appropriateness indicator rose again, con-
firming that the intervention established was not as effective
as other interventions that were proposed (7). Strategies for
managing test appropriateness require ongoing re-education
of clinicians with respect to test requests. However, problems
arose when we tried to reduce the 24 h demand for test
requests due to high turnover of clinicians and limited lab-
oratory staff.
With regard to pre-analytical KPIs, most of the studies
associated with patient identification error indicators referred
to inpatient identification wristbands (8), which were not
available for outpatients. We proposed using incorrect demo-
graphic data register KPIs to detect data needed to verify
tests, or contacting the requesting doctor if necessary. The
transport indicator was an important key point because early
sample delivery favors timely reporting. The courier record-
ed the delivery time. Awareness that the delivery time is part
of an indicator result that is summarized in a monthly report
involved the courier in the overall test process and encour-
aged improved courier performance. The unsuitable sample
model KPI was valuable. It can be used for any error and
sample, provided that the result of the affected test is coded.
Increased patient satisfaction appears to result from improve-
ments in the overall laboratory process.
We included a unique synthetic analytical quality indicator
for every functional unit. The advantage was that any KPI
deviation was analyzed to establish corrective measures. By
increasing the target Sigma value, continuous quality
improvement in the functional unit can be achieved.
Post-analytical KPIs were feasible because they were cal-
culated using intern LIS registers. The ‘‘TSH verified on
phlebotomy day’’ KPI results rose spectacularly, according
to goal implementation. Setting an objective and then mon-
itoring over time made it possible to achieve the objective.
It is completely different to state that ‘‘we processed all the
samples every day’’ from stating ‘‘last month 95% of TSH
requests were verified and made available to the requesting
doctor on the day of phlebotomy.’’ ANA TAT results also
improved according to the goal established.
Every KPI was designed and later validated in daily prac-
tice. Once the KPI was designed and validated, a set of
objectives was established. KPIs were monitored and KPI
results delivered each month to the personnel involved in the
process (laboratory functional unit, clinicians, couriers, etc.).
This was done to promote feedback and continuous improve-
ment in processing and laboratory performance, as assessed
in the study. This interchange of indicator results promotes
‘‘healthy competition’’, thereby changing corporate culture.
Each worker is motivated to improve their personal results
and those of the initial stages, which improves the entire
process and ultimately benefits patients.
Conclusions
We demonstrate how laboratory performance could be
enhanced using a model design based on a Data Warehouse
application that continuously collects registers (using the
data required for the daily testing process) and calculates
KPIs, which requires indicators that are reliable and accept-
able and usable.
The evolution of most of the indicator results over the past
years suggests that it is not enough to design and implement
indicators. It is essential to set goals and deliver the results
to those involved in the process. Continuous improvement in
performance can be achieved through communication and
teamwork (9, 10), which are the basis for patient safety.
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